TrialPediatric blood & cancer2025

A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors.

Filemon S Dela Cruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.